These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5491284)

  • 1. [Possibilities of choleretics in the treatment of digestive insufficiency].
    Grossi F; Grassi M
    Clin Ter; 1970 Aug; 54(3):267-72. PubMed ID: 5491284
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new treatment of digestive functional disorders: Sabilase].
    Chevrel B
    Med Chir Dig; 1977; 6(4):225-8. PubMed ID: 329019
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of Ora-Gallin in digestive insufficiency].
    Dierel HL
    Wien Med Wochenschr; 1967 Jul; 117(27):698-701. PubMed ID: 5598254
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biliary dynamics and cholagogue therapy in relation to the behavior of the colon].
    Messini M; Grossi F
    Arch Ital Sci Farmacol; 1965; 15(1):77-9. PubMed ID: 5871025
    [No Abstract]   [Full Text] [Related]  

  • 5. [Indications and contraindications of choleretic therapy].
    Grossi F
    Clin Ter; 1974; 70(2):108-9. PubMed ID: 4409826
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the application of "ido-genabil" for the therapy of indigestion in domestic animals].
    Winkler R
    Wien Tierarztl Monatsschr; 1967 Apr; 54(4):241-53. PubMed ID: 5631385
    [No Abstract]   [Full Text] [Related]  

  • 7. [Enzyme substitution therapy in digestive system diseases with special consideration of patients treated with tuberculostatic agents].
    Piacenza F
    Med Welt; 1967 May; 21():1321-5. PubMed ID: 5612545
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacological and clinical aspects of the use of a new choleretic, 1-morpholinoacetyl-3-phenyl-4-oxo-1,2,3,4-tetrahydroquinazoline hydrochloride].
    Grossi F; Spada S
    Clin Ter; 1969 Aug; 50(3):203-32. PubMed ID: 5387397
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical experiences with the amphocholereticum Oddibil].
    Zawodsky L
    Wien Med Wochenschr; 1974 Nov; 124(46):677-80. PubMed ID: 4617977
    [No Abstract]   [Full Text] [Related]  

  • 10. [New approches in the field of enzymatic therapy of gastrointestinal diseases].
    De Barbieri A
    Rev Bras Med; 1968 Oct; 25(10):655-63. PubMed ID: 5719711
    [No Abstract]   [Full Text] [Related]  

  • 11. [The choleretics].
    Geoffroy H; Dezoteux H
    Maroc Med; 1967 Jul; 47(504):506-11. PubMed ID: 5613355
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacotherapy of the upper gastrointestinal tract diseases in children with birth defects and minor anomalies of the heart development].
    Ataiants OK; Shashel' VA
    Eksp Klin Gastroenterol; 2012; (1):50-4. PubMed ID: 22808779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholagogues and choleretics.
    Hunt T
    Practitioner; 1971 Jan; 206(231):51-5. PubMed ID: 5540194
    [No Abstract]   [Full Text] [Related]  

  • 14. [Administration of erythromycin].
    Grym J
    Cesk Pediatr; 1991 May; 46(5):306-7. PubMed ID: 1893476
    [No Abstract]   [Full Text] [Related]  

  • 15. [Action on the extrahepatic bile ducts of a choleretic compound: imechromone].
    Grossi F; Spada S
    Clin Ter; 1969 Oct; 51(1):41-7. PubMed ID: 5364032
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of physical exercise during drug therapy of chronic cholecystoangiocholitis (clinicophysiological study)].
    Ragimov DM
    Vopr Kurortol Fizioter Lech Fiz Kult; 1970; 35(6):518-21. PubMed ID: 5515370
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of primary biliary cirrhosis].
    Szalay F
    Orv Hetil; 2003 Sep; 144(36):1787-8. PubMed ID: 14579676
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the treatment of hepatobiliary diseases with phytopharmaceutics].
    Glitsch HW
    Hippokrates; 1965 Sep; 36(18):726-9. PubMed ID: 5324310
    [No Abstract]   [Full Text] [Related]  

  • 19. [Odeston in treatment of chronic diseases of hepatobiliary system].
    Nasonova SV; Lebedeva OI
    Voen Med Zh; 2001 Feb; 322(2):49-53. PubMed ID: 11338822
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy with choleretics and bile kinetics].
    Ritter U
    Med Monatsschr Pharm; 1984 Apr; 7(4):99-104. PubMed ID: 6717369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.